Valvular Heart Disease
Study shows dentists should give antibiotics to high-risk patients to help prevent infectious endocarditis.
1 Sep, 2022 | 11:43h | UTCOriginal Study: Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: UK dentists should give antibiotics to patients at risk of heart infection – study – The Guardian
Long-term results of a RCT | Self-expanding transcatheter vs. surgical aortic valve replacement in intermediate-risk patients.
31 Aug, 2022 | 11:38h | UTCSelf-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Original article: Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients – New England Journal of Medicine
Commentary on Twitter
Among intermediate-risk patients with symptomatic severe aortic stenosis, clinical outcomes at 5 years were similar and bioprosthetic valve performance remained stable after transcatheter aortic valve replacement and surgery. https://t.co/rVcVoSMpG4 #OrigResearch
— JAMA Cardiology (@JAMACardio) August 26, 2022
Consensus Statement | Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis.
30 Aug, 2022 | 12:10h | UTC
Commentary on Twitter
Lipoprotein(a) in atherosclerotic CV and aortic stenosis – a European Atherosclerosis Society consensus statement https://t.co/Bzzpd3Bx8M
#EHJ #ESCCongress #ESCYoung @escardio @ehj_ed @rladeiraslopes pic.twitter.com/ZcqaPe581K
— European Society of Cardiology Journals (@ESC_Journals) August 29, 2022
#ESCCongress – RCT | In patients with rheumatic heart disease–associated atrial fibrillation, treatment with a Vitamin K antagonist led to a lower rate of cardiovascular events or death compared to Rivaroxaban.
29 Aug, 2022 | 12:33h | UTCRivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Trial backs standard of care for rheumatic heart disease and atrial fibrillation – European Society of Cardiology
Commentary: INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF – TCTMD
Commentary on Twitter
INVICTUS: In patients with RHD-associated AF, compared to rivaroxaban, VKA reduced cardiovascular events and mortality without increasing bleeding. #ESCCongress https://t.co/4C45LmmB5o pic.twitter.com/9n3OelzZvp
— NEJM (@NEJM) August 28, 2022
Cohort Study | Patients with bicuspid aortic stenosis were younger, had worse perioperative left ventricular function, and increased risk of postoperative heart failure compared to patients with tricuspid aortic stenosis.
23 Aug, 2022 | 12:54h | UTC
Cohort Study | Prediction of rapid progression among patients with moderately severe rheumatic mitral stenosis.
17 Aug, 2022 | 13:18h | UTC
Temporal changes, patient characteristics, and mortality, according to microbiological cause of infective endocarditis: a nationwide study.
12 Aug, 2022 | 14:38h | UTC
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.
12 Aug, 2022 | 14:48h | UTC
Bicuspid aortic valve stenosis: from pathophysiological mechanism, imaging diagnosis, to clinical treatment methods.
10 Aug, 2022 | 12:22h | UTC
Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement.
4 Aug, 2022 | 14:35h | UTC
Commentary on Twitter
Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Reviewhttps://t.co/xaUpRTD0rd@JACCJournals pic.twitter.com/IINRrOtXRY
— Giuseppe Biondi-Zoccai (@gbiondizoccai) July 26, 2022
Under a http://creativecommons.org/licenses/by/4.0/ license
Deep learning electrocardiographic analysis for detection of left-sided valvular heart disease.
3 Aug, 2022 | 14:19h | UTC
Commentary from the author on Twitter (thread – click for more)
Out today in @JACCJournals, our ValveNet study shows a ML model can detect mod-severe left sided valve disease from ECG. This model is currently running live in our health system daily. Now let me tell you everything wrong with it! A brief 🧵 https://t.co/rjtZxxTLt9 pic.twitter.com/oZKDDnZqYU
— Pierre Elias, MD (@PierreEliasMD) August 1, 2022
Cohort Study | Association between early left ventricular ejection fraction improvement after transcatheter aortic valve replacement and 5-year clinical outcomes.
3 Aug, 2022 | 13:58h | UTCAssociation Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes – JAMA Cardiology (link to abstract – $ for full-text)
Commentary: Early LV Recovery After TAVI Points to Better 5-Year Survival – TCTMD
Commentary on Twitter
In patients with severe #aorticstenosis and left ventricular ejection fraction (LVEF) less than 50%, 1 in 3 experience LVEF improvement within 1 month after TAVR. Early LVEF improvement is associated with lower 5-year all-cause and cardiac death. https://t.co/81H6roA8nV
— JAMA Cardiology (@JAMACardio) July 27, 2022
Global burden of rheumatic heart disease: trends from 1990 to 2019.
1 Aug, 2022 | 12:07h | UTCGlobal burden of rheumatic heart disease: trends from 1990 to 2019 – Arthritis Research & Therapy
Commentary: Death, disability from rheumatic heart disease decreased globally from 1990 to 2019 – Healio (free registration required)
Cohort Study | Impact of peridevice leak on 5-year outcomes after left atrial appendage closure.
29 Jul, 2022 | 12:26h | UTCImpact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: Peridevice Leaks After LAA Occlusion Signal Poorer 5-Year Outcomes – TCTMD
M-A | Mortality and clinical predictors after percutaneous mitral valve repair for secondary mitral regurgitation.
26 Jul, 2022 | 11:49h | UTC
M-A | Mid- to long-term clinical and echocardiographic effects of post-procedural permanent pacemaker implantation after transcatheter aortic valve replacement.
18 Jul, 2022 | 11:10h | UTC
Consensus Statement | Clinical indications and triaging for adult transthoracic echocardiography.
14 Jul, 2022 | 12:47h | UTC
Cohort Study | Risk and timing of noncardiac surgery after transcatheter aortic valve implantation.
13 Jul, 2022 | 11:43h | UTCCommentaries:
Surgery After TAVR: Waiting a Month or More Not Really Better— Prosthesis-patient mismatch, paravalvular regurgitation the bigger issues for surgical candidates – MedPage Today (free registration required)
Commentaries on Twitter
https://twitter.com/JAMANetworkOpen/status/1545120466326749186
https://twitter.com/preopconsult/status/1546167570771894272
Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome.
7 Jul, 2022 | 12:38h | UTC
M-A | DOACs vs. VKAs in atrial fibrillation patients with bioprosthetic heart valve.
7 Jul, 2022 | 12:15h | UTC
Echocardiographic guidance in transcatheter structural cardiac interventions.
1 Jul, 2022 | 11:28h | UTCEchocardiographic guidance in transcatheter structural cardiac interventions – EuroIntervention
Commentary on Twitter
This richly illustrated State-of-the-Art review focuses on echocardiographic guidance for the most common catheter-based interventions, providing several tips and tricks for practical interventional cardiologists. #EAPCI https://t.co/7bTlMHrzNO pic.twitter.com/l94jms2XK1
— EuroIntervention (@EuroInterventio) February 19, 2022
Rheumatic heart disease is a neglected disease relative to its burden worldwide: findings from Global Burden of Disease 2019.
28 Jun, 2022 | 11:17h | UTC